Correction of the galactocerebrosidase deficiency in globoid cell leukodystrophy-cultured cells by SL3-3 retroviral-mediated gene transfer

被引:16
作者
Sosa, MAG [1 ]
DeGasperi, R [1 ]
Undevia, S [1 ]
Yeretsian, J [1 ]
Rouse, SC [1 ]
Lyerla, T [1 ]
Kolodny, EH [1 ]
机构
[1] CLARK UNIV, DEPT BIOL, WORCESTER, MA 01610 USA
关键词
D O I
10.1006/bbrc.1996.0136
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Globoid cell leukodystrophy (GCL) or Krabbe disease is an autosomal recessive inherited disease caused by the deficiency of galactocerebrosidase, the lysosomal enzyme responsible for the degradation of galactocerebroside, a major component of myelin. An animal model homologue of GCL is the twitcher mouse. In the present wort, using novel recombinant retroviruses harboring the SL3-3 LTR, we have been able to stably correct the galactocerebrosidase deficiency in twitcher mouse TM-2 cells and in primary human fibroblasts from a patient with globoid cell leukodystrophy. These results show the possibility of retroviral-mediated gene therapy for the treatment of GCL. (C) 1996 Academic Press, Inc.
引用
收藏
页码:766 / 771
页数:6
相关论文
共 28 条